$CAPR In the US alone there are 10,000 young men in wheelchairs who can benefit from Deramiocel.
The peer reviewed Lancet article stated both skeletal and cardiac muscle benefit (pp.2,9)
The Robustness analysis said the benefits are not "fragile"...they are ROBUST !
The American Heart Association Award is for the cardiac benefit !
All the DMD families want is for their boys to have better quality and longer lives. That is what we all want for our kids!
The FDA says they want to treat rare diseases fairly...now let them do what they say!
Bullish
Every time $NIO builds real momentum, the exact same two-pronged attack hits the tape:
• A wave of coordinated social media bashers pushing recycled FUD
• Relentless algorithmic shorting & suspected naked short pressure
Hiring independent forensic investigators to uncover who is bankrolling both the online smear campaigns and the trading desks would be a game-changer—not just for $NIO, but for all heavily shorted Chinese stocks.
Expose the manipulators and let the fundamentals speak. Bullish on $NIO!
$IBRX Two major points of many I enjoyed from yesterday’s conf call. Adcock stating top-line header numbers will be released at a medical conference ‘to ensure a greatest speaking slot’. BULLISH
Also IBRX to ask the FDA to let patients receive the drug with their first course of BCG.
With stellar top-line results, will the FDA approve that request? $$
“When Jefferies analyst Roger Song pressed Adcock on that point, Adcock said ImmunityBio was in talks to present the full results at a medical meeting. “The reason we have not provided the top-line head numbers yet is that we are working with medical congresses to present all of that, and if you give out in a press release, then they do not want to give you the great speaking slot on those.”
“At two London conferences, ImmunityBio (IBRX) CEO Richard Adcock put a new number behind Anktiva’s bladder cancer trial win and said the company plans to ask the FDA within weeks to let patients receive the drug with their first course of BCG.”
Bullish
Wall Street is pricing $HUMA for bankruptcy while ignoring a potential 50x–100x market expansion. 👀
Let’s look at the facts:
• Hospital adoption is up 44% with recurring revenue kicking in
• First device is FDA-approved—making the second device (backed by stellar data) a high-probability catalyst
• The dialysis market is 50–100x larger, and >50% of those patients are hard-to-reach
You don't need to wait for final approval to see fireworks—the run-up alone could be huge.
If management keeps executing, big medtech will try to buy $HUMA out before it gets too expensive.
AI data centers are booming, but here's the thing nobody should ignore…
$KEEL proposed 96MW Sherbrooke project still has some local hurdles to clear. The company is holding another public meeting on November 25, and local officials are already talking about tighter rules for data centers.
Let's be real — having a big AI opportunity means nothing if you can't get the approvals to build it.I'm still watching KEEL, but I'll be keeping a close eye on the permitting process. That's what matters now.
Nebius Group ($NBIS) reported revenue of $980.8 million for the third quarter of 2026—a 571% year-over-year increase—along with $12 billion in new contract value for the quarter. Management projects 2027 revenue to reach between $12 billion and $13 billion, with the company expected to reach a pre-tax break-even point. Furthermore, of the $40 billion to $45 billion in planned capital expenditures, 75% to 85% is expected to be covered through customer prepayments and asset-backed financing.
THE NEXT BIG WEALTH CREATION CYCLE COULD BE ROBOTICS.
Top 10 Robotics Stocks to Own in 2026 and Beyond:
$AMD
| Leading AI semiconductor company supplying processors for robotics. Q3 2026 revenue increased 45% YoY to $13.4B.
$NBIS
The fact is had Bloom energy actually delivered power like they said they could on their own earnings call when DataOne started shutting down their illegal generators, Nebius would have actually crushed earnings not by the 8.4% they did, but by 38% and they still beat despite Bloom's failure to execute. That's how you should look at what occurred, things outside company control still couldn't stop them from beating earnings. Because of that 3rd party failure to execute, they will now recognize that revenue and ARR 2 months out instead, it didn't go anywhere. Now that revenue will instead juice another quarter when it's counted. Trading at 2.3x forward price to sales on a hyper growth globally scaling Ai hyperscaler? Had to buy more. Over 100% customer capex coverage, the capacity customers aren't paying for is being sold at 2x what customers are paying! Much ado about nothing.
$RKLB I don't celebrate or take any pleasure in ULA's launch failure yesterday, quite the opposite. However, it does and should make a Rocket Lab investor realize how indispensable the companies are that can reliably get in LEO and beyond. This fact alone partly justifies the multiple RKLB trades at, and should be taken into consideration when assessing how expensive this stock is from a valuation standpoint.
Bullish
$KEEL Keel is the best value play right now. Its fallen the most out of the ai datacentre family. Its simply the best deal by far. Hive's at 1.6 and was at 4.2 at its peak. Keels at 1.8 and was at 7.4. The max value potential is just far greater.
Big news for $UBER and $AMZN today!
Amazon-owned Zoox has officially launched its fully autonomous robotaxis on the Uber app in Las Vegas.
The companies also announced a new multiyear partnership with MGM Resorts, with plans to expand to Los Angeles in 2027.
Love seeing Uber continue to expand its autonomous vehicle partnerships.
$WULF $NUAI $NBIS $IREN $NVDA We have an ULTRA CRAZY week ahead of us! First we have all the "Jensen is Returning" news. Then on Tuesday we have NVDA earnings and especially the EARNINGS CALL which will be full of surprises. THEN we have the ANTHROPIC IPO on Thursday which will be one of the biggest and most anticipated IPOs in history! To make sure everything goes great and we get the BULLISH PARABOLIC INSANITY we all crave I am posting a pic of BOTH 'Jensen Stepping Up' ...AND... the Green Money Lizard. Jensen and the Lizard will work TOGETHER so we get the INSANE GAINS we lust after!!!
$IBRX Here's a summary of the presentation:
We have thrown AnkTiva at every cure and it has worked amazingly based on the data and results with no side effects.
That's it. It just heals.
Bullish
$ADMA fasten your seatbeelts 🚀
Interesting Detail in ADMA’s Latest SEC Filing!
NOVEMBER 2026: ADMA’s Q3 10-Q explicitly states:
“We continue to evaluate a variety of strategic alternatives, and the exploration of value-creating opportunities remains a top corporate priority.”
DECEMBER 2022: ADMA confirmed receiving multiple non-binding acquisition offers during its strategic review with Morgan Stanley. The Board considered the offers financially inadequate.
MAY 2023: ADMA confirmed that its strategic review with Morgan Stanley was still ongoing.
AUGUST 2023: ADMA terminated its advisory agreement with Morgan Stanley but continued evaluating strategic alternatives.
The interesting part: ADMA previously received actual acquisition offers, rejected them as inadequate, and continues to identify strategic alternatives as a top corporate priority.
This does not confirm any current acquisition offers or ongoing buyout negotiations.
$ONDS When national security outweighs politics.
Despite Ireland’s stance against Israeli technology, Irish police reportedly deployed Ondas-owned Sentrycs counter-drone systems to protect European leaders.
That’s a powerful endorsement of Sentrycs technology on the international stage.
Real-world deployments. Growing global credibility. Bullish $ONDS.
🩰Frequently laugh and let go of your concerns. One afternoon, Clara asks Lila to join a town potluck gathering, taking place in the square beneath the ancient oak tree.
🌏Products are sent to customers. Joy from the results!The trail levels out, and I can see the trailhead in the distance. I pick up my pace a little, eager to get back, but also savoring the last few moments of being in the forest. The golden leaves are beautiful, and I take one
Comfort grieving sad upset friends with quiet patient silent steady presence, because calm silent companionship mends heavy inner sadness far better than long complicated comforting speeches spoken out loud.